Invention Grant
- Patent Title: Nicotinamide phosphoribosyltransferase (NAMPT) mutant and use thereof
-
Application No.: US15574849Application Date: 2016-07-30
-
Publication No.: US10174298B2Publication Date: 2019-01-08
- Inventor: Rongzhao Fu , Qi Zhang
- Applicant: BONTAC BIO-ENGINEERING(SHENZHEN) CO., LTD
- Applicant Address: CN Shenzhen
- Assignee: BONTAC BIO-ENGINEERING(SHENZHEN) CO., LTD
- Current Assignee: BONTAC BIO-ENGINEERING(SHENZHEN) CO., LTD
- Current Assignee Address: CN Shenzhen
- Agent Gokalp Bayramoglu
- International Application: PCT/CN2016/092456 WO 20160730
- International Announcement: WO2018/023206 WO 20180208
- Main IPC: C12N9/10
- IPC: C12N9/10 ; C12P19/30

Abstract:
The present invention discloses a Nicotinamide phosphoribosyltransferase (nampt) mutant and use thereof. The present invention relates to a nicotinamide phosphoribosyltransferase (Nampt) mutant artificially obtained through genic site-directed mutation. An object of the present invention is to provide a Nampt mutant having a catalytic activity higher than that of a conventional wild type parent, wherein the enzymatic activity of the Nampt mutant provided in the present invention is 1.2-6.9 times of the enzymatic activity of the parent.
Public/Granted literature
- US20180230443A1 NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) MUTANT AND USE THEREOF Public/Granted day:2018-08-16
Information query